Immunohistochemical detection of BRAF mutation in melanoma

被引:0
|
作者
Vernali, Michelle [1 ]
Zedek, Dan [2 ]
Ollila, David W. [3 ]
Thomas, Nancy E. [2 ]
机构
[1] Univ N Carolina, Sch Med, Chapel Hill, NC USA
[2] Univ N Carolina, Sch Med, Dept Dermatol, Chapel Hill, NC 27514 USA
[3] Univ N Carolina, Sch Med, Dept Surg Oncol, Chapel Hill, NC USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P7571
引用
收藏
页码:AB1 / AB1
页数:1
相关论文
共 50 条
  • [21] Analysis of BRAF mutation in primary and metastatic melanoma
    Libra, M
    Malaponte, G
    Navolanic, PM
    Gangemi, P
    Bevelacqua, V
    Proietti, L
    Bruni, B
    Stivala, F
    Mazzarino, MC
    Travali, S
    McCubrey, JA
    CELL CYCLE, 2005, 4 (10) : 1382 - 1384
  • [22] Lack of BRAF mutation in primary uveal melanoma
    Cohen, Y
    Goldenberg-Cohen, N
    Parrella, P
    Chowers, I
    Merbs, SL
    Pe'er, J
    Sidransky, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (07) : 2876 - 2878
  • [23] BRAF mutation testing on melanoma brain metastases
    Barresi, V.
    Simone, A.
    Scarf, R.
    De Luca, G.
    Lentini, M.
    Caltabiano, R.
    Lanzafame, S.
    Antonelli, M.
    Giuffre, G.
    VIRCHOWS ARCHIV, 2014, 465 : S327 - S328
  • [24] Detection of BRAF V600E Mutation in Melanoma: Comparison Between Immunohistochemistry and Three Gene Mutation Detection Methods
    Xu, W.
    Shaimaa, L.
    Wakkas, F.
    James, H.
    Declan, S.
    Mohammad, I.
    Somaia, E.
    JOURNAL OF PATHOLOGY, 2020, 250 : 12 - 12
  • [25] Application of a BRAF pyrosequencing assay for mutation detection and copy number analysis in malignant melanoma
    Spittle, Cynthia
    Ward, M. Renee
    Nathanson, Katherine L.
    Gimotty, Phyllis A.
    Rappaport, Eric
    Brose, Marcia S.
    Medina, Angelica
    Letrero, Richard
    Herlyn, Meenhard
    Edwards, Robin H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (04): : 464 - 471
  • [26] Detection of BRAF Mutation in Metastatic Melanoma Utilizing Cell-Transferred Cytological Smears
    Chen, Shaoxiong
    Randolph, Melissa
    Cramer, Harvey M.
    Watkins, Tracy
    McCullough, Holly
    Post, Kristin M.
    Sen, Joyashree D.
    Cheng, Liang
    Wu, Howard H.
    ACTA CYTOLOGICA, 2014, 58 (05) : 478 - 482
  • [27] A validation study for the use VE1 immunohistochemical staining in screening for BRAF mutation in cutaneous malignant melanoma
    Zhang, Weiming
    Song, Guoxin
    Han, Xue
    Li, Xiao
    Luo, Dan
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (11): : 4886 - 4890
  • [28] Immunohistochemical detection of BRAF V600E mutation status in anaplastic thyroid carcinoma
    Rushton, Sarah
    Burghel, George
    Wallace, Andrew
    Nonaka, Daisuke
    HISTOPATHOLOGY, 2016, 69 (03) : 524 - 526
  • [29] BRAFV600 mutation detection in tricky melanoma samples using the new IdyllaTM BRAF Mutation Test
    Riveiro-Falkenbach, E.
    Ruano, Y.
    Garcia-Martin, R. M.
    Rodriguez-Peralto, J. L.
    VIRCHOWS ARCHIV, 2016, 469 : S201 - S202
  • [30] Patient with stage IV melanoma with BRAF mutation - immunotherapy or BRAF and MEK inhibitors?
    Cybulska-Stopa, Bozena
    Ziobro, Marek
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 (02): : 100 - 103